Lumos Diagnostics Holdings Ltd (LDX) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.149x

Based on the latest financial reports, Lumos Diagnostics Holdings Ltd (LDX) has a cash flow conversion efficiency ratio of 0.149x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$778.03K ≈ $550.51K USD) by net assets (AU$5.24 Million ≈ $3.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See LDX cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Lumos Diagnostics Holdings Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Lumos Diagnostics Holdings Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Lumos Diagnostics Holdings Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lumos Diagnostics Holdings Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Innovate Corp NYSE:VATE	-0.092x
Plastron Precision Co Ltd TWO:6185	0.049x
TSA KLSE:0297	0.108x
Groupe LDLC SA PA:ALLDL	-0.164x
Ace Technologies Corp KQ:088800	0.045x
Superior Plating Technology Co Ltd TWO:8431	-0.024x
Cheviot Company Limited NSE:CHEVIOT	0.072x
Samart Telcoms Public Company Limited BK:SAMTEL	0.208x

Annual Cash Flow Conversion Efficiency for Lumos Diagnostics Holdings Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Lumos Diagnostics Holdings Ltd from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see LDX market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$6.16 Million ≈ $4.36 Million	AU$-9.33 Million ≈ $-6.60 Million	-1.516x	-1239.24%
2023-12-31	AU$7.11 Million ≈ $5.03 Million	AU$946.00K ≈ $669.36K	0.133x	+113.11%
2022-12-31	AU$9.50 Million ≈ $6.72 Million	AU$-9.64 Million ≈ $-6.82 Million	-1.015x	-0.62%
2021-12-31	AU$17.89 Million ≈ $12.65 Million	AU$-18.04 Million ≈ $-12.76 Million	-1.008x	-439.75%
2020-12-31	AU$58.28 Million ≈ $41.24 Million	AU$-10.89 Million ≈ $-7.70 Million	-0.187x	-10.16%
2019-12-31	AU$22.16 Million ≈ $15.68 Million	AU$-3.76 Million ≈ $-2.66 Million	-0.170x	+34.83%
2018-12-31	AU$11.66 Million ≈ $8.25 Million	AU$-3.03 Million ≈ $-2.15 Million	-0.260x	-168.72%
2017-12-31	AU$2.98 Million ≈ $2.11 Million	AU$-288.67K ≈ $-204.25K	-0.097x	--

About Lumos Diagnostics Holdings Ltd

AU:LDX Australia Medical Devices

Market Cap

$68.64 Million

AU$97.01 Million AUD

Market Cap Rank

#20623 Global

#699 in Australia

Share Price

AU$0.11

Change (1 day)

+0.00%

52-Week Range

AU$0.03 - AU$0.32

All Time High

AU$1.22